全文获取类型
收费全文 | 1611篇 |
免费 | 132篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 92篇 |
妇产科学 | 17篇 |
基础医学 | 158篇 |
口腔科学 | 44篇 |
临床医学 | 233篇 |
内科学 | 364篇 |
皮肤病学 | 88篇 |
神经病学 | 91篇 |
特种医学 | 250篇 |
外科学 | 116篇 |
综合类 | 22篇 |
预防医学 | 95篇 |
眼科学 | 17篇 |
药学 | 56篇 |
中国医学 | 5篇 |
肿瘤学 | 95篇 |
出版年
2023年 | 9篇 |
2022年 | 10篇 |
2021年 | 17篇 |
2020年 | 12篇 |
2019年 | 11篇 |
2018年 | 37篇 |
2017年 | 29篇 |
2016年 | 32篇 |
2015年 | 32篇 |
2014年 | 47篇 |
2013年 | 50篇 |
2012年 | 45篇 |
2011年 | 40篇 |
2010年 | 51篇 |
2009年 | 65篇 |
2008年 | 50篇 |
2007年 | 45篇 |
2006年 | 48篇 |
2005年 | 39篇 |
2004年 | 38篇 |
2003年 | 51篇 |
2002年 | 54篇 |
2001年 | 48篇 |
2000年 | 37篇 |
1999年 | 36篇 |
1998年 | 64篇 |
1997年 | 59篇 |
1996年 | 74篇 |
1995年 | 54篇 |
1994年 | 54篇 |
1993年 | 50篇 |
1992年 | 23篇 |
1991年 | 20篇 |
1990年 | 29篇 |
1989年 | 52篇 |
1988年 | 37篇 |
1987年 | 44篇 |
1986年 | 47篇 |
1985年 | 27篇 |
1984年 | 18篇 |
1983年 | 12篇 |
1982年 | 26篇 |
1981年 | 16篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 17篇 |
1974年 | 14篇 |
1970年 | 9篇 |
排序方式: 共有1750条查询结果,搜索用时 15 毫秒
1.
C. J. M. Antens M. Oldenwening A. Wolse U. Gehring H. A. Smit R. C. Aalberse M. Kerkhof J. Gerritsen J. C. de Jongste B. Brunekreef 《Clinical and experimental allergy》2006,36(12):1525-1531
BACKGROUND: Studies of the association between indoor allergen exposure and the development of allergic diseases have often measured allergen exposure at one point in time. OBJECTIVE: We investigated the variability of house dust mite (Der p 1, Der f 1) and cat (Fel d 1) allergen in Dutch homes over a period of 8 years. METHODS: Data were obtained in the Dutch PIAMA birth cohort study. Dust from the child's mattress, the parents' mattress and the living room floor was collected at four points in time, when the child was 3 months, 4, 6 and 8 years old. Dust samples were analysed for Der p 1, Der f 1 and Fel d 1 by sandwich enzyme immuno assay. RESULTS: Mite allergen concentrations for the child's mattress, the parents' mattress and the living room floor were moderately correlated between time-points. Agreement was better for cat allergen. For Der p 1 and Der f 1 on the child's mattress, the within-home variance was close to or smaller than the between-home variance in most cases. For Fel d 1, the within-home variance was almost always smaller than the between-home variance. Results were similar for allergen levels expressed per gram of dust and allergen levels expressed per square metre of the sampled surface. Variance ratios were smaller when samples were taken at shorter time intervals than at longer time intervals. CONCLUSION: Over a period of 4 years, mite and cat allergens measured in house dust are sufficiently stable to use single measurements with confidence in epidemiological studies. The within-home variance was larger when samples were taken 8 years apart so that over such long periods, repetition of sampling is recommended. 相似文献
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.